I don’t know if Mark Eller and Doug “Emo” Emerson read Seneca, but I thought of the Stoic Roman philosopher when I contacted these two older Boulder athletes in order to try out rowing and cycling as a complement to my running.
/PRNewswire/ twoXAR, Inc., a Delaware corporation focused on discovering and bringing first-in-class small molecules to market, today announced that the.
My Journey From Skepticism To Conviction Regarding AI
Source: Life Science Leader
By Mark Eller
Drug development is a complex, highly regulated practice that relies, most importantly, on experiments and their results.
The initial discovery step relies on human insight to generate hypotheses worth testing in the first experiments. Insights come through knowledge, experience, patience and instinct. Best practices are handed down from researcher to researcher, which in turn helps companies build and refine their hypotheses and grow their pipelines. That has been the traditional path to drug discovery. Another is that computers and artificial intelligence (AI) can replace this traditional model and expedite the entire process. The dichotomy between these two approaches is very real.